Bührer E, D'Haese D, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A, Hentrich Met al.(2024) Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium Eur J Cancer, 202, 114042 DOI 10.1016/j.ejca.2024.114042, PubMed 38564927
Gerdtsson A, Negaard HFS, Almås B, Bergdahl AG, Cohn-Cedermark G, Glimelius I, Halvorsen D, Haugnes HS, Hedlund A, Hellström M, Holmberg G, Karlsdóttir Á, Kjellman A, Larsen SM, Thor A, Wahlqvist R, Ståhl O, Tandstad T(2024) Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours BJU Int(in press) DOI 10.1111/bju.16289, PubMed 38293778
Switlyk MD, Hopland A, Reitan E, Sivanesan S, Brennhovd B, Axcrona U, Hole KH(2023) Multiparametric Magnetic Resonance Imaging of Penile Cancer: A Pictorial Review Cancers (Basel), 15(22) DOI 10.3390/cancers15225324, PubMed 38001583